HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Use of erythropoiesis-stimulating agents: an ongoing controversy
-
- Are restrictions on ESA use justified?
- BRCA mutations in women with ovarian cancer correlated with longer survival
- CDC report: Nearly 20% of Americans cannot afford needed health care
- Congress delays 10.1% cut to Medicare physician payments
- Congress increases scrutiny of Medicare Recovery Audit Contractors Anthony H. Choe, JD, MPH
- Lung cancer: the invisible disease Toby C. Campbell, MD, MSCI
- Metastatic colorectal cancer: timing and selecting best management options Wajeeha Razaq, MD
- Progress in the treatment of PNH: decisions, decisions, decisions Wendell F. Rosse, MD
-
- Bloodletting: an early treatment used by barbers, surgeons
- Imaging of human reporter genes has translational applications Ronald Blasberg, MD
- Factor V Leiden and prothrombin mutation linked to venous thrombosis
- Lenalidomide decreases transfusion dependence in MDS not related to 5q deletion
- Rivaroxaban efficacious after orthopedic surgery
- Manpower needed in Eritrea
- End-of-life care: when chemotherapy may not be the best option Thomas J. Smith, MD; Keith M. Swetz, MD